TrialJournal of the National Cancer Institute2013

Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial.

Shuji Ogino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.